Neo Kuma Ventures
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Psychedelic Healthcare Investment Fund
Investor Profile
Neo Kuma Ventures has made 7 investments, with 0 in the past 12 months and 29% as lead.
Stage Focus
- Seed (57%)
- Series A (14%)
- Convertible Note (14%)
- Pre Seed (14%)
Country Focus
- United Kingdom (57%)
- United States (43%)
Industry Focus
- Health Care
- Personal Health
- Biotechnology
- Information Technology
- Gaming
- Mental Health
- Virtual Reality
- Wellness
- Medical
- Continuing Education
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.